TheProfitWatch

QLGN - Qualigen Therapeutics, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
3.92 0.07 (1.79%) --- --- 0.0 (0.0%) -0.07 (-1.79%) 0.19 (5.0%) 0.0 (0.0%) 0.0 (0.0%)

Qualigen Therapeutics Inc is an early-clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer. The company's business consists of one early-clinical-stage therapeutic program (QN-302) and one preclinical therapeutic program. The company's program, QN-302, is an investigational small-molecule G-quadruplexes (G4)-selective transcription inhibitor with binding affinity to G4s prevalent in cancer cells.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Closed

Earnings & Ratios

Basic EPS:
-1.0
Diluted EPS:
-1.0
Basic P/E:
-3.99
Diluted P/E:
-3.99
RSI(14) 1m:
100.0
VWAP:
3.99
RVol:
0.0341

Events

Period Kind Movement Occurred At
1m Price decrease 1m 3.94 -0.05 (-1.22%) Oct 15 15:25
10m Price decrease 10m 3.94 -0.16 (-3.9%) Oct 15 13:06
1m Price decrease 1m 3.94 -0.04 (-1.13%) Oct 15 13:06
1m Price decrease 1m 3.98 -0.06 (-1.49%) Oct 15 13:02
1m Price increase 1m 4.3 +0.07 (+1.65%) Oct 15 11:01

Related News